Skip to main content
. 2020 Jan 24;117(4):43–50. doi: 10.3238/arztebl.2020.0043

Table 2. Prescriptions of hepatotoxic drugs in patients with acute liver failure (n= 4621 patients) compared with the general population*1.

Hepatotoxic drug Patients with ALF *3 General population*4 Comparison with general population
(n) (% of all) (n) (% of all) (%) (p)
Painkillers
Ibuprofen*2 310 6.7 7 145 928 8.7 -1.97 <0.001
Diclofenac 77 1.7 2 177 394 2.6 -0.98 <0.001
Acetaminophen*2 34 0.7 991 534 1.2 -0.47 0.017
Antibiotics
Amoxicillin 122 2.6 2 035 862 2.5 0.17 0.481
Ciprofloxacin 139 3.0 1 031 971 1.3 1.76 <0.001
Trimethoprim/sulfamethoxazole 71 1.5 405 784 0.5 1.04 <0.001
Levofloxacin 39 0.8 289 716 0.4 0.48 <0.001
Nitrofurantoin 16 0.3 114 144 0.1 0.21 0.002
Others
Phenprocoumon 67 1.5 829 865 1.0 0.45 0.006
Carbamazepine 7 0.1 207 871 0.3 -0.11 0.221
Cytostatic preparations 87 1.9 101 846 0.1 1.77 <0.001
All 4621 82 341 288

ALF – acute liver failure

*1 Comparison performed using a two-sided binominal test.

*2 Prescriptions only. Over-the-counter-medications are not included.

*3 Number of ALF patients with at least one prescription in the 3 months before coding of ALF

*4 The numbers of patients with at least one prescription were recorded for every quarter during the study period. The average numbers of patients per quarter are presented.